These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 16679324

  • 1. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles.
    Ebner T, Sommergruber M, Moser M, Shebl O, Schreier-Lechner E, Tews G.
    Hum Reprod; 2006 Aug; 21(8):2022-6. PubMed ID: 16679324
    [Abstract] [Full Text] [Related]

  • 2. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J.
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [Abstract] [Full Text] [Related]

  • 3. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M.
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [Abstract] [Full Text] [Related]

  • 4. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA, El-Haieg DO, El-Sebaey A.
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [Abstract] [Full Text] [Related]

  • 5. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P.
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [Abstract] [Full Text] [Related]

  • 6. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
    Cupisti S, Dittrich R, Mueller A, Strick R, Stiegler E, Binder H, Beckmann MW, Strissel P.
    Eur J Med Res; 2007 Dec 14; 12(12):604-8. PubMed ID: 18024272
    [Abstract] [Full Text] [Related]

  • 7. Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation.
    La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, Volpe A.
    Hum Reprod; 2004 Dec 14; 19(12):2738-41. PubMed ID: 15459174
    [Abstract] [Full Text] [Related]

  • 8. Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.
    La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, Volpe A.
    Hum Reprod; 2007 Mar 14; 22(3):766-71. PubMed ID: 17071823
    [Abstract] [Full Text] [Related]

  • 9. Anti-mullerian hormone as a marker of ovarian reserve.
    Tremellen KP, Kolo M, Gilmore A, Lekamge DN.
    Aust N Z J Obstet Gynaecol; 2005 Feb 14; 45(1):20-4. PubMed ID: 15730360
    [Abstract] [Full Text] [Related]

  • 10. Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes.
    Irez T, Ocal P, Guralp O, Cetin M, Aydogan B, Sahmay S.
    Arch Gynecol Obstet; 2011 Nov 14; 284(5):1295-301. PubMed ID: 21748312
    [Abstract] [Full Text] [Related]

  • 11. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.
    Fertil Steril; 2009 Nov 14; 92(5):1586-93. PubMed ID: 18930213
    [Abstract] [Full Text] [Related]

  • 12. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM, Guibourdenche J, Birkhäuser MH, Bersinger NA.
    Fertil Steril; 2008 Dec 14; 90(6):2203-10. PubMed ID: 18291376
    [Abstract] [Full Text] [Related]

  • 13. Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy.
    Nelson SM, Yates RW, Fleming R.
    Hum Reprod; 2007 Sep 14; 22(9):2414-21. PubMed ID: 17636277
    [Abstract] [Full Text] [Related]

  • 14. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism.
    Eldar-Geva T, Margalioth EJ, Gal M, Ben-Chetrit A, Algur N, Zylber-Haran E, Brooks B, Huerta M, Spitz IM.
    Hum Reprod; 2005 Jul 14; 20(7):1814-9. PubMed ID: 15802320
    [Abstract] [Full Text] [Related]

  • 15. Stable serum levels of anti-Müllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women.
    Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy Ch, Englert Y.
    Hum Reprod; 2007 Jul 14; 22(7):1837-40. PubMed ID: 17485437
    [Abstract] [Full Text] [Related]

  • 16. [Usefulness of inhibin B, serum progesterone, and AMH concentrations obtained during controlled ovarian hyperstimulation (COH) in predicting ovarian response and oocyte quality].
    Dewailly D.
    J Gynecol Obstet Biol Reprod (Paris); 2006 Sep 14; 35(5 Pt 2):2S44-2S46. PubMed ID: 17057624
    [Abstract] [Full Text] [Related]

  • 17. Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women.
    Kevenaar ME, Themmen AP, Laven JS, Sonntag B, Fong SL, Uitterlinden AG, de Jong FH, Pols HA, Simoni M, Visser JA.
    Hum Reprod; 2007 Jun 14; 22(6):1547-54. PubMed ID: 17337470
    [Abstract] [Full Text] [Related]

  • 18. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P.
    BJOG; 2005 Oct 14; 112(10):1384-90. PubMed ID: 16167941
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
    McIlveen M, Skull JD, Ledger WL.
    Hum Reprod; 2007 Mar 14; 22(3):778-85. PubMed ID: 17114197
    [Abstract] [Full Text] [Related]

  • 20. Anti-Müllerian hormone concentrations in maternal serum during pregnancy.
    La Marca A, Giulini S, Orvieto R, De Leo V, Volpe A.
    Hum Reprod; 2005 Jun 14; 20(6):1569-72. PubMed ID: 15734752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.